Literature DB >> 11686551

In vitro release of activin A from human normal and pathological thyroid tissues.

P S Morpurgo1, A Corsi, S Corbetta, L Vicentini, A Spada.   

Abstract

Activin A is a dimeric glycoprotein belonging to the transforming growth factor beta (TGF-beta) superfamily characterized by the ability to affect FSH secretion. Activin A was originally indicated as a gonadal product but the expression of activin A has been successively identified in several different tissues, including the thyroid gland. The aim of this study was to evaluate the release of activin A from human normal and pathological thyroid tissues in culture. Activin A concentration was evaluated in media obtained from primary culture of perinodular normal tissues (no.=2), hyperplastic hyperfunctioning thyroid tissues due to Graves' disease (no.=3) and autonomous thyroid adenomas (no.=3). Detectable levels of activin A were found in the incubation media from all tissues, without significant differences between normal and pathological samples. We conclude that activin A is secreted by follicle thyroid cells in normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11686551     DOI: 10.1007/BF03343893

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  12 in total

Review 1.  A novel role of activin in inflammation and repair.

Authors:  B Munz; G Hübner; Y Tretter; C Alzheimer; S Werner
Journal:  J Endocrinol       Date:  1999-05       Impact factor: 4.286

2.  Gonadal and extragonadal expression of inhibin alpha, beta A, and beta B subunits in various tissues predicts diverse functions.

Authors:  H Meunier; C Rivier; R M Evans; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

3.  Local extragonadal roles of activins.

Authors:  L M Bilezikjian; W W Vale
Journal:  Trends Endocrinol Metab       Date:  1992-08       Impact factor: 12.015

4.  Serum immunoreactive activin A levels in normal subjects and patients with various diseases.

Authors:  K Harada; Y Shintani; Y Sakamoto; M Wakatsuki; K Shitsukawa; S Saito
Journal:  J Clin Endocrinol Metab       Date:  1996-06       Impact factor: 5.958

Review 5.  Chemical and biological characterization of the inhibin family of protein hormones.

Authors:  W Vale; C Rivier; A Hsueh; C Campen; H Meunier; T Bicsak; J Vaughan; A Corrigan; W Bardin; P Sawchenko
Journal:  Recent Prog Horm Res       Date:  1988

6.  Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid.

Authors:  W Vale; J Rivier; J Vaughan; R McClintock; A Corrigan; W Woo; D Karr; J Spiess
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

7.  Activin A and activin receptors in the human thyroid: a link to the female predominance of goiter?

Authors:  K M Schulte; C Jonas; R Krebs; H D Röher
Journal:  Horm Metab Res       Date:  2000-10       Impact factor: 2.936

8.  Expression of transforming growth factor-beta1, activin A, and their receptors in thyroid follicle cells: negative regulation of thyrocyte growth and function.

Authors:  A Franzén; E Piek; B Westermark; P ten Dijke; N E Heldin
Journal:  Endocrinology       Date:  1999-09       Impact factor: 4.736

9.  Immunohistochemical localization of activin A and follistatin in human tissues.

Authors:  M Wada; Y Shintani; M Kosaka; T Sano; K Hizawa; S Saito
Journal:  Endocr J       Date:  1996-08       Impact factor: 2.349

10.  The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes.

Authors:  J L Dube; P Wang; J Elvin; K M Lyons; A J Celeste; M M Matzuk
Journal:  Mol Endocrinol       Date:  1998-12
View more
  1 in total

1.  Reversible increase of serum activin A levels in women with Graves' disease.

Authors:  M Centanni; N Viceconti; S Luisi; F M Reis; L Gargano; F Maiani; A Franchi; G Canettieri; F Petraglia
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.